These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 1445330)

  • 1. Preferential cyclization of 2,3(S):22(S),23-dioxidosqualene by mammalian 2,3-oxidosqualene-lanosterol cyclase.
    Boutaud O; Dolis D; Schuber F
    Biochem Biophys Res Commun; 1992 Oct; 188(2):898-904. PubMed ID: 1445330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a supernatant protein on microsomal squalene epoxidase and 2,3-oxidosqualene-lanosterol cyclase.
    Saat YA; Bloch KE
    J Biol Chem; 1976 Sep; 251(17):5155-60. PubMed ID: 956181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a 2,3-oxidosqualene-lanosterol cyclase inhibitor 2,3:22,23-dioxidosqualene and 24,25-epoxycholesterol on the regulation of cholesterol biosynthesis in human hepatoma cell line HepG2.
    Dollis D; Schuber F
    Biochem Pharmacol; 1994 Jul; 48(1):49-57. PubMed ID: 8043030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives.
    Viola F; Brusa P; Balliano G; Ceruti M; Boutaud O; Schuber F; Cattel L
    Biochem Pharmacol; 1995 Sep; 50(6):787-96. PubMed ID: 7575639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cholesterol biosynthesis in 3T3 fibroblasts by 2-aza-2,3-dihydrosqualene, a rationally designed 2,3-oxidosqualene cyclase inhibitor.
    Gerst N; Schuber F; Viola F; Cattel L
    Biochem Pharmacol; 1986 Dec; 35(23):4243-50. PubMed ID: 3790151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of 2,3-oxidosqualene cyclase from rat liver.
    Moore WR; Schatzman GL
    J Biol Chem; 1992 Nov; 267(31):22003-6. PubMed ID: 1429550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lanosterol biosynthesis in the prokaryote Methylococcus capsulatus: insight into the evolution of sterol biosynthesis.
    Lamb DC; Jackson CJ; Warrilow AG; Manning NJ; Kelly DE; Kelly SL
    Mol Biol Evol; 2007 Aug; 24(8):1714-21. PubMed ID: 17567593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase.
    Viola F; Ceruti M; Balliano G; Caputo O; Cattel L
    Farmaco; 1990 Sep; 45(9):965-78. PubMed ID: 2282128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and stereoelectronic requirements for the inhibition of mammalian 2,3-oxidosqualene cyclase by substituted isoquinoline derivatives.
    Barth MM; Binet JL; Thomas DM; de Fornel DC; Samreth S; Schuber FJ; Renaut PP
    J Med Chem; 1996 Jun; 39(12):2302-12. PubMed ID: 8691425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a supernatant protein activator on microsomal squalene-2,3-oxide-lanosterol cyclase.
    Caras IW; Bloch K
    J Biol Chem; 1979 Dec; 254(23):11816-21. PubMed ID: 500676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of fungal and mammalian sterol biosynthesis by 2-aza-2,3-dihydrosqualene.
    Ryder NS; Dupont MC; Frank I
    FEBS Lett; 1986 Aug; 204(2):239-42. PubMed ID: 3525224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic Mechanism of Lanosterol: Cyclization.
    Chen N; Wang S; Smentek L; Hess BA; Wu R
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8693-6. PubMed ID: 26069216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial purification of 2,3-oxidosqualene-lanosterol cyclase from hog-liver. Evidence for a functional thiol residue.
    Duriatti A; Schuber F
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1378-85. PubMed ID: 3355560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squalene epoxidase and oxidosqualene lanosterol-cyclase activities in cholesterogenic and non-cholesterogenic tissues.
    Astruc M; Tabacik C; Descomps B; de Paulet AC
    Biochim Biophys Acta; 1977 Apr; 487(1):204-11. PubMed ID: 857899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and inhibition studies of sulfur-substituted squalene oxide analogues as mechanism-based inhibitors of 2,3-oxidosqualene-lanosterol cyclase.
    Stach D; Zheng YF; Perez AL; Oehlschlager AC; Abe I; Prestwich GD; Hartman PG
    J Med Chem; 1997 Jan; 40(2):201-9. PubMed ID: 9003518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Affinity labeling of vertebrate oxidosqualene cyclases with a tritiated suicide substrate.
    Abe I; Bai M; Xiao XY; Prestwich GD
    Biochem Biophys Res Commun; 1992 Aug; 187(1):32-8. PubMed ID: 1520315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors.
    Cattel L; Ceruti M; Balliano G; Viola F; Grosa G; Rocco F; Brusa P
    Lipids; 1995 Mar; 30(3):235-46. PubMed ID: 7791532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insight into steroid scaffold formation from the structure of human oxidosqualene cyclase.
    Thoma R; Schulz-Gasch T; D'Arcy B; Benz J; Aebi J; Dehmlow H; Hennig M; Stihle M; Ruf A
    Nature; 2004 Nov; 432(7013):118-22. PubMed ID: 15525992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture.
    Van Sickle WA; Angelastro MR; Wilson P; Cooper JR; Marquart A; Flanagan MA
    Lipids; 1992 Mar; 27(3):157-60. PubMed ID: 1326069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 29-Methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase.
    Ceruti M; Rocco F; Viola F; Balliano G; Milla P; Arpicco S; Cattel L
    J Med Chem; 1998 Feb; 41(4):540-54. PubMed ID: 9484504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.